Titan Bio-Tech share news, announcements and annual reports
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹360.45.
30 Oct: open ₹364.90, high ₹364.95, low ₹335.40
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,755 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 51.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 49,199
Titan Bio-Tech share news and announcements
606 announcements, routine notices left out, newest first. Page 9 of 13.
Oct 2018
20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 020 Oct · Shareholding for the Period Ended September 30, 2018
Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....1 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2018
28 Sep · Meeting
1 Sep · Meeting
Aug 2018
7 Aug · Results
Jul 2018
18 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....16 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Jun 2018
13 Jun · Issue Of Duplicate Share Certificate
May 2018
Apr 2018
18 Apr · Compliance Certificate Under Reg.7(3) Of SEBI(LODR)Regulations,2015 For The Half Year Ended 31.03.2018
17 Apr · Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2018.
17 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 014 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
Feb 2018
Jan 2018
17 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
Dec 2017
26 Dec · Board Meeting On January 03, 2018.
Nov 2017
14 Nov · Results
2 Nov · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Oct 2017
27 Oct · Compliance Certificate Under Regulation 40(9) Of SEBI( Listing Obligations And Disclosure Requirements) Regulations 2015
26 Oct · Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations 2015 For The Half Yearly September 2017
16 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....16 Oct · Statement Of Investor Compliant Report As On 30Th September, 2017
Sep 2017
Aug 2017
9 Aug · Change in Corporate Office Address
Jul 2017
18 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....13 Jul · Statement Of Investors Complaints For The Quarter Ended 30Th June,2017.